Literature DB >> 12766775

Rheb is an essential regulator of S6K in controlling cell growth in Drosophila.

Hugo Stocker1, Thomas Radimerski, Benno Schindelholz, Franz Wittwer, Priyanka Belawat, Pierre Daram, Sebastian Breuer, George Thomas, Ernst Hafen.   

Abstract

Understanding the mechanisms through which multicellular organisms regulate cell, organ and body growth is of relevance to developmental biology and to research on growth-related diseases such as cancer. Here we describe a new effector in growth control, the small GTPase Rheb (Ras homologue enriched in brain). Mutations in the Drosophila melanogaster Rheb gene were isolated as growth-inhibitors, whereas overexpression of Rheb promoted cell growth. Our genetic and biochemical analyses suggest that Rheb functions downstream of the tumour suppressors Tsc1 (tuberous sclerosis 1)-Tsc2 in the TOR (target of rapamycin) signalling pathway to control growth, and that a major effector of Rheb function is ribosomal S6 kinase (S6K).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766775     DOI: 10.1038/ncb995

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  208 in total

1.  Size matters. Workshop on growth control in development and disease.

Authors:  Duojia Pan
Journal:  EMBO Rep       Date:  2004-01-23       Impact factor: 8.807

Review 2.  mTOR signaling in cancer cell motility and tumor metastasis.

Authors:  Hongyu Zhou; Shile Huang
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

3.  Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death.

Authors:  Long Chen; Baoshan Xu; Lei Liu; Yan Luo; Hongyu Zhou; Wenxing Chen; Tao Shen; Xiuzhen Han; Christopher D Kontos; Shile Huang
Journal:  Free Radic Biol Med       Date:  2010-12-30       Impact factor: 7.376

4.  Diminished MTORC1-Dependent JNK Activation Underlies the Neurodevelopmental Defects Associated with Lysosomal Dysfunction.

Authors:  Ching-On Wong; Michela Palmieri; Jiaxing Li; Dmitry Akhmedov; Yufang Chao; Geoffrey T Broadhead; Michael X Zhu; Rebecca Berdeaux; Catherine A Collins; Marco Sardiello; Kartik Venkatachalam
Journal:  Cell Rep       Date:  2015-09-17       Impact factor: 9.423

5.  The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.

Authors:  T R Hartman; E Nicolas; A Klein-Szanto; T Al-Saleem; T P Cash; M C Simon; E P Henske
Journal:  Oncogene       Date:  2009-02-23       Impact factor: 9.867

6.  Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development.

Authors:  Yann-Gaël Gangloff; Matthias Mueller; Stephen G Dann; Petr Svoboda; Melanie Sticker; Jean-Francois Spetz; Sung Hee Um; Eric J Brown; Silvia Cereghini; George Thomas; Sara C Kozma
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 7.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

8.  Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.

Authors:  Xue Qing Lun; Hongyuan Zhou; Tommy Alain; Beichen Sun; Limei Wang; John W Barrett; Marianne M Stanford; Grant McFadden; John Bell; Donna L Senger; Peter A Forsyth
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

9.  The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1.

Authors:  Liron Bar-Peled; Lynne Chantranupong; Zhi-Yang Tsun; Roberto Zoncu; Tim Wang; Choah Kim; Eric Spooner; David M Sabatini
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

10.  The Rheb switch 2 segment is critical for signaling to target of rapamycin complex 1.

Authors:  Xiaomeng Long; Yenshou Lin; Sara Ortiz-Vega; Susann Busch; Joseph Avruch
Journal:  J Biol Chem       Date:  2007-04-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.